This report looks at the refocusing in approach across pharmaceutical medicines and tries to learn whether the COVID-19 pandemic has brought about permanent changes to pharmaceutical medicine and drug development and regulations that could, or should, now become integrated into ‘normal’ practice.
You can download the report here.